Literature DB >> 9894962

A comparison of the clinical profile of cavernous malformations with and without associated venous malformations.

S I Abdulrauf1, M Y Kaynar, I A Awad.   

Abstract

OBJECTIVE: Little is known about the clinical behavior of cavernous malformations (CMs) associated with venous malformations (VMs) of the brain. The aim of this study is to compare the clinical profile of patients harboring CMs with and without associated VMs.
METHODS: A retrospective analysis of 55 consecutive patients harboring CMs of the brain who presented to a single neurovascular team during a 4-year period was performed. Forty-two patients (76%) had CMs alone (CM group), and 13 patients (24%) had CMs associated with VMs (CM + VM group). Detailed clinical information regarding each patient was gathered. Statistical analysis was performed using Fisher's exact test for binary variables and Mann-Whitney U test for continuous variables.
RESULTS: The lesion location was infratentorial for 19 of the 70 CMs (27%) in the CM group and for 14 of the 21 CMs (67%) in the CM + VM group (P = 0.001). Familial histories of CMs were documented for 7 of the 42 patients (17%) in the CM group and none of the 13 patients in the CM + VM group. There was a female-to-male gender bias of 1.6:1 in the CM group and 3.3:1 in the CM + VM group. Sixteen of the 42 patients (38%) in the CM group and 8 of the 13 patients (62%) in the CM + VM group presented with symptomatic hemorrhage. Seizure presentation was documented in 11 of the 42 patients (26%) in the CM group and in 1 of the 13 patients (8%) in the CM + VM group. Repeated symptomatic hemorrhage was diagnosed in 4 of the 42 patients (9.5%) in the CM group and in 3 of the 13 patients (23%) in the CM + VM group. There were no apparent differences in the mean age at presentation, lesion size, or multiplicity between the two groups.
CONCLUSION: Patients with CMs associated with VMs are more likely to be female patients, have associated symptomatic hemorrhage, have lesions in the posterior fossa (statistically significant), suffer from repeated symptomatic hemorrhage, and are less likely to present with seizures or to have familial histories when compared with patients with CMs alone. The possible mechanisms for these apparent differences in clinical profile are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 9894962     DOI: 10.1097/00006123-199901000-00020

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  41 in total

Review 1.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 2.  Developmental venous anomalies of the brain in children -- imaging spectrum and update.

Authors:  Luke L Linscott; James L Leach; Blaise V Jones; Todd A Abruzzo
Journal:  Pediatr Radiol       Date:  2016-01-21

3.  Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas.

Authors:  M Fuetsch; F El Majdoub; M Hoevels; R P Müller; V Sturm; M Maarouf
Journal:  Strahlenther Onkol       Date:  2012-04       Impact factor: 3.621

Review 4.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

5.  Angiographic detection of cerebral cavernous malformations with C-arm cone beam CT imaging in three patients.

Authors:  Martin G Radvany; Daniele Rigamonti; Philippe Gailloud
Journal:  BMJ Case Rep       Date:  2013-05-22

Review 6.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

7.  Evaluation of sporadic intracranial cavernous malformations for detecting associated developmental venous anomalies: added diagnostic value of C-arm contrast-enhanced cone-beam CT to routine contrast-enhanced MRI.

Authors:  Burak Kocak; Osman Kizilkilic; Amalya Zeynalova; Bora Korkmazer; Naci Kocer; Civan Islak
Journal:  Eur Radiol       Date:  2018-07-31       Impact factor: 5.315

8.  Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.

Authors:  Romuald Girard; Maged D Fam; Hussein A Zeineddine; Huan Tan; Abdul Ghani Mikati; Changbin Shi; Michael Jesselson; Robert Shenkar; Meijing Wu; Ying Cao; Nicholas Hobson; Henrik B W Larsson; Gregory A Christoforidis; Issam A Awad
Journal:  J Neurosurg       Date:  2016-08-05       Impact factor: 5.115

9.  Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.

Authors:  T A Petersen; L A Morrison; R M Schrader; B L Hart
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

10.  Immune response in human cerebral cavernous malformations.

Authors:  Changbin Shi; Robert Shenkar; Hongyan Du; Edward Duckworth; Harish Raja; H Hunt Batjer; Issam A Awad
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.